NYSE:NGVTChemicals
Assessing Ingevity (NGVT) Valuation After Impairment Charge And 2026 Guidance Update
Ingevity (NGVT) shares came into focus after the company booked a long lived assets impairment charge of US$109.3 million in the fourth quarter and paired that with fresh 2026 net sales guidance.
See our latest analysis for Ingevity.
The impairment charge and weaker quarterly results appear to have cooled short term sentiment, with a 7 day share price return of 7.76% decline and a 30 day share price return of 9.09% decline. However, the 90 day share price return of 17.89% and 1 year total...